Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
ROE: Strong ReturnsExpanding
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-116.74%
↑ 20% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-145.22%
Historical baseline
PeriodValueYoY Change
2024-116.74%+13.0%
2023-134.19%-170.2%
2022-49.66%-47.4%
2021-33.69%+7.0%
2020-36.23%+90.7%
2019-387.97%-44.5%
2018-268.41%-37.9%
2017-194.58%-44.1%
2016-135.06%-41.2%
2015-95.68%-